In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030

Market-Research

Roots Analysis has done a detailed study on ““In Vitro ADME Testing Services Market, 2019-2030” covering key

Submitted by Roots_Analysis on 2020-06-18 11:24.

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030

Market-Research

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions

Submitted by Roots_Analysis on 2020-06-18 11:14.

In vitro ADME testing services market is likely to be worth USD 2.2

Market-Research

Submitted by Roots_Analysis on 2020-06-18 11:07.

The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030

Market-Research

Key Inclusions

A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters, such as

Submitted by Roots_Analysis on 2020-06-18 10:58.

Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug

Market-Research

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel ... Read more

Submitted by Roots_Analysis on 2020-06-18 10:52.

The biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%

Market-Research

Roots Analysis has done a detailed study on Biopharma Contract ... Read more

Submitted by Roots_Analysis on 2020-06-18 10:44.

The biopharmaceutical contract manufacturing market

Market-Research

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

Submitted by Roots_Analysis on 2020-06-18 10:33.

The “Antibody Contract Manufacturing Market, 2020-2030

Market-Research

Key Inclusions

A detailed review of the overall landscape of companies, offering contract services for the manufacturing of antibodies, along with information on year of establishment, company size, scale of operation (preclinical, clinical and commercial),

Submitted by Roots_Analysis on 2020-06-17 09:07.

Several companies worldwide claim to possess the required expertise and infrastructure to offer contract manufacturing services

Market-Research

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there ... Read more

Submitted by Roots_Analysis on 2020-06-17 08:59.

The antibody contract manufacturing market is projected to grow at an annualized rate of 12%, till 2030

Market-Research

Roots Analysis has done a detailed study on Antibody Contract Manufacturing Market, 2020-2030, covering key aspects of the ... Read more

Submitted by Roots_Analysis on 2020-06-17 08:48.

The antibody contract manufacturing market

Market-Research

The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well

Submitted by Roots_Analysis on 2020-06-17 08:42.

The ‘Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030

Market-Research

Key Inclusions

A detailed review of the current market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain, and detailed analysis based on a number of relevant parameters, such

Submitted by Roots_Analysis on 2020-06-17 08:34.

Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services

Market-Research

More than 130 medical devices were approved by the FDA since January 2018, while several are currently being evaluated across more than 9,500 (active) clinical trials, worldwide. Even though technical innovation has enabled the development of a variety of versatile medical devices, ... Read more

Submitted by Roots_Analysis on 2020-06-17 08:25.

The contract regulatory affairs-management services market for medical devices

Market-Research

Roots Analysis has done a detailed study on Medical Device CROs for Regulatory Affairs Management Market, 2019-2030, covering key aspects of the industry’s ... Read more

Submitted by Roots_Analysis on 2020-06-17 08:17.

The contract regulatory affairs-management services market

Market-Research

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

Submitted by Roots_Analysis on 2020-06-17 08:04.

The “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030

Market-Research

Key Inclusions

A detailed review of the overall landscape of the non-invasive cancer diagnostics market, featuring information on the developers of such products and analyses based on a number of relevant parameters, such as year of establishment, company size,

Submitted by Roots_Analysis on 2020-06-15 08:31.

Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers

Market-Research

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.

To order this 350 ... Read more

Submitted by Roots_Analysis on 2020-06-15 08:24.

The non-invasive cancer diagnostics market is projected to grow at an annualized

Market-Research

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-06-15 08:15.

The non-invasive cancer diagnostics market

Market-Research

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access

Submitted by Roots_Analysis on 2020-06-15 08:06.

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates

Market-Research

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, autoinjectors, needle-free injectors ... Read more

Submitted by Roots_Analysis on 2020-06-15 07:57.

Pages